Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 9Lymphoid 5Plasma cell 4Myeloid 3Classical hematology 3Genitourinary 1

Conditions

Myelodysplastic Syndromes 9Anemia, Aplastic 9Leukemia 8Lymphoma 6Leukemia, Myeloid, Acute 5Myeloproliferative Disorders 4Multiple Myeloma 4Hodgkin Disease 4Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hematologic Neoplasms 3Polycythemia Vera 2Neutropenia, Severe Congenital, Autosomal Recessive 3 2Immunologic Deficiency Syndromes 2Histiocytosis 2Hemoglobinuria, Paroxysmal 2Congenital Abnormalities 2Bone Marrow Failure Disorders 2Blast Crisis 2Anemia, Sickle Cell 2Anemia, Refractory, with Excess of Blasts 2Anemia, Diamond-Blackfan 2beta-Thalassemia 1Thrombocythemia, Essential 1Shwachman-Diamond Syndrome 1Recurrence 1Primary Immunodeficiency Diseases 1

Interventions

fludarabine 10Cyclophosphamide 8fludarabine phosphate 7Whole-Body Irradiation 7Tacrolimus 5Mycophenolic Acid 5Melphalan 5Thiotepa 4Peripheral Blood Stem Cell Transplantation 4Busulfan 4AP 1903 reagent 4thymoglobulin 3Sirolimus 3Cord Blood Stem Cell Transplantation 3Alemtuzumab 3Stem Cell Transplantation 2Specimen Handling 2Rituximab 2Platelet Transfusion 2Meropenem 2Cyclosporine 2Biopsy 2Antilymphocyte Serum 2visilizumab 1venetoclax 1trametinib 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Alemtuzumab × Classical hematology × Clear all
NCT00997386 2019-09-09

ALBUM

University of Arizona

Phase 2 Completed
16 enrolled 7 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hemoglobinuria, Paroxysmal, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Hematologic Neoplasms, Primary Myelofibrosis

NCT00618969 2016-03-03

Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors

University of Arizona

Phase 2 Completed
2 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hemoglobinuria, Paroxysmal, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT00056966 2012-06-29

Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

Baylor College of Medicine

Phase 1/2 Completed
24 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡